Literature DB >> 14190467

THE PRESERVATION OF BRADYKININ BY PHENOTHIAZINES IN VITRO.

W KRIVOY, D KROEGER.   

Abstract

Chlorpromazine and phenoxybenzamine have been shown to potentiate the actions of bradykinin in vivo. To test whether this phenomenon could be due to inhibition of the enzymatic destruction of bradykinin, bradykinin was incubated with either tissue extracts or with carboxypeptidase B. Bradykinin was rapidly destroyed by acetonedried powders of brain and serum of various animals as well as by purified carboxypeptidase B. The rate of disappearance of bradykinin activity was decreased in the presence of phenothiazine derivatives, phenoxybenzamine and hydroxyzine, but not by compounds of a larger group including other psychotropic drugs, tranquillizers and ganglionic and adrenergic blocking agents. Spectrophotometric studies of the hydrolysis of hippuryl-L-arginine confirmed the presence of a carboxypeptidase B-like activity in brain. The substances that acted as inhibitors of bradykinin destruction were also enzyme inhibitors as measured by this technique. Previous incubation of carboxypeptidase B with phenothiazines and zinc ions greatly reduced the enzymatic inhibition by the phenothiazines, which indicated a possible chelating action by these inhibitors on the metalo-enzyme carboxypeptidase B.

Entities:  

Keywords:  BIRDS; BRADYKININ; BRAIN CHEMISTRY; CARBOXYPEPTIDASES; CATS; CATTLE; CHLORPROMAZINE; CHYMOTRYPSIN; DOGS; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; GANGLIONIC BLOCKADERS; HALLUCINOGENS; IMIPRAMINE; INDOLES; PHARMACOLOGY; PHENOXYBENZAMINE; PSILOCYBINE; RABBITS; RATS; SWINE; SYMPATHOLYTICS; TRANQUILIZING AGENTS

Mesh:

Substances:

Year:  1964        PMID: 14190467      PMCID: PMC1703993          DOI: 10.1111/j.1476-5381.1964.tb02037.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  10 in total

1.  The actions of certain polypeptides on synaptic transmission.

Authors:  W A KRIVOY; M LANE; D C KROEGER
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  The "active catalytic site," an approach through metalloenzymes.

Authors:  B L VALLEE
Journal:  Fed Proc       Date:  1961-09

3.  Properties and classification of some brain peptidases.

Authors:  L L UZMAN; S VAN DEN NOORT; M K RUMLEY
Journal:  J Neurochem       Date:  1962 May-Jun       Impact factor: 5.372

4.  Potentiation of bradykinin by dimercaptopropanol (bal) and other inhibitors of its destroying enzyme in plasma.

Authors:  S H FERREIRA; M ROCHA E SILVA
Journal:  Biochem Pharmacol       Date:  1962-12       Impact factor: 5.858

5.  An enzyme in human blood plasma that inactivates bradykinin and kallidins.

Authors:  E G ERDOS; E M SLOANE
Journal:  Biochem Pharmacol       Date:  1962-07       Impact factor: 5.858

6.  The intralaminar distribution of dipeptidase activity in human frontal isocortex.

Authors:  A POPE
Journal:  J Neurochem       Date:  1959-04       Impact factor: 5.372

7.  Carboxy-peptidase B. 4. Purification and characterization of the porcine enzyme.

Authors:  J E FOLK; K A PIEZ; W R CARROLL; J A GLADNER
Journal:  J Biol Chem       Date:  1960-08       Impact factor: 5.157

8.  The catabolism of some physiologically active polypeptides by homogenate of dog hypothalamus.

Authors:  K C HOOPER
Journal:  Biochem J       Date:  1962-06       Impact factor: 3.857

9.  Potentiation of duration of the vasodilator effect of bradykinin by sympatholytic drugs and by reserpine.

Authors:  M ROCHA E SILVA; A P CORRADO; A O RAMOS
Journal:  J Pharmacol Exp Ther       Date:  1960-03       Impact factor: 4.030

10.  Vascular responses of the rat to bradykinin.

Authors:  S LLOYD
Journal:  Br J Pharmacol Chemother       Date:  1962-12
  10 in total
  2 in total

1.  Adrenolytic and sympatholytic properties of 2-halogenoalkylamines in the vas deferens of the guinea-pig.

Authors:  J D Graham; A L Katib H
Journal:  Br J Pharmacol Chemother       Date:  1967-09

2.  The in vitro inactivation and formation of plasma kinins by spleen cathepsins.

Authors:  L M Greenbaum; K Yamafuji
Journal:  Br J Pharmacol Chemother       Date:  1966-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.